CHARYN TAB 500 MG CAJA C/3 ASPEN LABS PRINCIPIO ACTIVO: CANAGLIFLOZINA

Description

PRINCIPIO ACTIVO: CANAGLIFLOZINA

Concentración y contenido:3 G10 SOB

Contenido por sobre: 3150 mg

PERJETA 420 MG / 14 mL | Solución Inyectable | Frasco Ámpula | Roche

CHARYN TAB 500 MG CAJA C/3 ASPEN LABS PRINCIPIO ACTIVO: CANAGLIFLOZINASUSTANCIA: CHARYN TAB. 500 MG. CAJA C 3 FABRICANTE: WERMAR

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy